The ESCMID Study Group for Bloodstream Infections, Endocarditis, and Sepsis (ESGBIES) is committed to improving the management of bloodstream infections, infective endocarditis, and sepsis. This network of dedicated experts focuses on:
Through a strong dedication to research, ESGBIES drives forward to create educational initiatives, such as in-person seminars, courses, and webinars, as well as joint projects. Both longstanding and new members are appreciated for playing an invaluable role in this shared mission.
Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study).
Pascale R, Toschi A, Aslan AT, Massaro G, Maccaro A, Fabbricatore D, Dell'Aquila A, Ripa M, Işık ME,Kızmaz YU, Iacopino S, Camici M, Perna F, Akinosoglou K, Karruli A, Papadimitriou-Olivgeris M, Kayaaslan B, Bilir YA, Evren Özcan E, Turan OE, Işık MC, Pérez- RodríguezMT, Yagüe BL, Quirós AM, Yılmaz M, Petersdorf S, De Potter T, Durante- Mangoni E, Akova M, Curnis A,Gibertoni D, Diemberger I, Scudeller L, Viale P, Giannella M, CarDINe Study Group. Int J Antimicrob Agents. 2023;61(3):106734.
What is the best treatment for difficult-to-treat Pseudomonas aeruginosa infections/BSI?
15 January 2025, 13:00-14:00 CET
In which type of bloodstream infections follow-up blood cultures are needed?
11 December 2024
The best available therapy for BSI caused by MBL-producing Enterobacterales
26 June 2024
An echocardiography is needed in all patients with Enterococcus faecalis bacteraemia? PROS (Anders Dahl, Denmark) and CONS (Nuria Fernández-Hidalgo, Spain).
If you have questions or comments for our study group, we warmly invite you to contact us!